Abstract
Focal renal therapy for small renal masses (T1a or T 1b) has been used as primary treatment for patients with comorbidities who are considered poor candidates for surgical resection. With a continuing effort toward optimization of minimally invasive nephron-sparing modalities, the effort to expand the patient pool will continue. As long-term results of renal ablative therapies become available and the safety, precision, and efficacy become well established, renal ablation may be used with increasing frequency for a wider group of patients. When this happens, high-quality imaging for localization and targeting of these renal lesions will become the central core of the treatment, with emphasis on superior results, accurate positioning of the probe, precise localization of the tumor, and real-time intraoperative monitoring of outcomes.
| Original language | English |
|---|---|
| Pages (from-to) | 729-744 |
| Number of pages | 16 |
| Journal | Journal of Endourology |
| Volume | 24 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1 2010 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Urology
Cite this
Optimization of image-guided targeting in renal focal therapy. / Leveillee, Raymond J.; Ramanathan, Rajan.
In: Journal of Endourology, Vol. 24, No. 5, 01.05.2010, p. 729-744.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Optimization of image-guided targeting in renal focal therapy
AU - Leveillee, Raymond J.
AU - Ramanathan, Rajan
PY - 2010/5/1
Y1 - 2010/5/1
N2 - Focal renal therapy for small renal masses (T1a or T 1b) has been used as primary treatment for patients with comorbidities who are considered poor candidates for surgical resection. With a continuing effort toward optimization of minimally invasive nephron-sparing modalities, the effort to expand the patient pool will continue. As long-term results of renal ablative therapies become available and the safety, precision, and efficacy become well established, renal ablation may be used with increasing frequency for a wider group of patients. When this happens, high-quality imaging for localization and targeting of these renal lesions will become the central core of the treatment, with emphasis on superior results, accurate positioning of the probe, precise localization of the tumor, and real-time intraoperative monitoring of outcomes.
AB - Focal renal therapy for small renal masses (T1a or T 1b) has been used as primary treatment for patients with comorbidities who are considered poor candidates for surgical resection. With a continuing effort toward optimization of minimally invasive nephron-sparing modalities, the effort to expand the patient pool will continue. As long-term results of renal ablative therapies become available and the safety, precision, and efficacy become well established, renal ablation may be used with increasing frequency for a wider group of patients. When this happens, high-quality imaging for localization and targeting of these renal lesions will become the central core of the treatment, with emphasis on superior results, accurate positioning of the probe, precise localization of the tumor, and real-time intraoperative monitoring of outcomes.
UR - http://www.scopus.com/inward/record.url?scp=77952578902&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952578902&partnerID=8YFLogxK
U2 - 10.1089/end.2009.0622
DO - 10.1089/end.2009.0622
M3 - Article
C2 - 20477541
AN - SCOPUS:77952578902
VL - 24
SP - 729
EP - 744
JO - Journal of Endourology
JF - Journal of Endourology
SN - 0892-7790
IS - 5
ER -